BSE filing, NSE: ORIENTALTL. Summary written from the filing by ALFA Finder's alert engine.
Oriental Trimex Ltd: key numbers
- Share price
- ₹4.36
- Market cap
- ₹32.05 Cr
- Revenue (annual)
- ₹21.18 Cr
- Net profit (annual)
- ₹1.79 Cr
- P/E (TTM)
- 15.9×Sector 31.7×
- Promoter holding
- 25.85%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Oriental Trimex Ltd
All →Oriental Trimex Management Change
Oriental Trimex Limited has re-designated Mr. Nveen Joshi from Additional Director to Non-Executive Independent Director, effective September 28, 2026.
Oriental Trimex Annual General Meeting
Oriental Trimex held its 30th Annual General Meeting on September 28, 2026. Shareholders approved financial statements and the appointment of Mr. Naveen Joshi as Independent Director.
Oriental Trimex Annual General Meeting
Oriental Trimex Limited schedules its 30th Annual General Meeting for September 28, 2026, via video conferencing to transact ordinary and special business.
Oriental Trimex Management Change
Oriental Trimex Limited has appointed Mr. Naveen Joshi as a Non-Executive Independent Director and M/s. Bhawana and Associates as the Internal Auditor.
Oriental Trimex Board Meeting Outcome
Oriental Trimex approved its Board Report, the 30th AGM notice, and appointed a new Independent Director and an Internal Auditor during its board meeting.
Oriental Trimex Q1 FY27 Results: Net Profit ₹0.8 Cr, Up 33.3% YoY
Oriental Trimex Ltd reported revenue from operations of ₹7.9 Cr (+364.7% YoY) and net profit of ₹0.8 Cr (+33.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.8 Cr · +33.3% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.